DKI originally recommended Shockwave Medical ($SWAV) in December when the stock was at $190. A key part of our positive thesis on the stock was our expectation of a takeover at > $300. This morning, Johnson & Johnson ($JNJ) announced a deal to buy $SWAV for $335 in cash. I’d like to thank cardiologist and … Read more
This piece was originally published on March 26th, 2024 In December, DKI recommended Shockwave Medical ($SWAV) at $190. The thesis was the company was growing quickly due to an unchallenged best-in-class product enabling stent placement in cases that were difficult due to excessive calcification of an artery. We further said that the company was a … Read more
We’ve spent the last decade or so hearing about how electric vehicles would save the environment. EVs have been marketed as zero-emission vehicles and have benefited from both generous government subsidies and increasingly stringent regulations on conventional internal combustion vehicles. At Deep Knowledge Investing, we’re always interested in high-quality research that challenges conventional wisdom. When … Read more
